About SyAqua
SyAqua is a Healthcare company based in Honolulu (United States) founded in 2001, and was acquired by Ocean 14 Capital in June 2022. Genomic selection services are offered for shrimp breeding enhancement. SyAqua has completed 1 acquisition, including Primo. SyAqua offers products and services including Genetics Solutions, Nutrition and Health Products, and Facilities Consulting. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified. Its legal entity is SyAqua Sdn Bhd. Its competitors include Avidity Biosciences, Sutro Biopharma and Antheia; 3 of its 3 listed competitors have raised funding.
Company details
SyAqua was established in 2001 by SyGen as a specific pathogen-free Penaeus vannamei shrimp breeding program. Based in Honolulu, United States, operations began at the University of California Berkeley, focusing on quantitative genetics. Best Linear Unbiased Prediction (BLUP) was pioneered for estimating breeding values without physical tagging. Since 2011, a genetic markers panel has been developed to identify genes linked to quantitative traits for parent selection in breeding candidates.
- Headquarters Honolulu, United States
- Stage Acquired
- SectorsHealthcare
- Website syaqua.com
- Social LinkedIn
- Acquired by Ocean 14 Capital (Jun 2022)
- Legal Name Syaqua Sdn Bhd
- Investors
- Investments & Acquisitions
- Acquired byOcean 14 Capital
(Jun 2022)
Products & Services of SyAqua
SyAqua offers a comprehensive portfolio of products and services, including Genetics Solutions, Nutrition and Health Products, and Facilities Consulting.
Provides disease-resistant shrimp broodstocks for enhanced survival.
Develops specialized shrimp larval nutrition for optimal growth.
Offers advice on shrimp farm construction and management.
Investors in SyAqua
SyAqua has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ocean 14 Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in tech startups offering solutions to ocean sectors | ocean14capital.com | London, United Kingdom |
Investor details for SyAqua
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SyAqua
3 people are tracked at SyAqua (3 in leadership).
| Name | Role | Group |
|---|---|---|
Fred H. Kao | Chief Executive Officer | Leadership |
Wai Keong Wong | Finance Director, Gold Coin Syaqua Group (asia & Florida, Usa) | Leadership |
Adam Banaszak | Chief Commercial Officer | Leadership |
Complete people profiles for SyAqua
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SyAqua
SyAqua has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Primo.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Shrimp genetics services for disease-resistant Litopenaeus vannamei are provided. | primobroodstock.com | Mims, United States | 2000 | Jul 2024 | β’β’β’β’ |
Complete acquisition details for SyAqua
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of SyAqua
3 dated milestones of SyAqua across 23 years, from founding to its latest funding, stage changes and deals.
- Founded SyAqua is founded.
- Exit Acquired by Ocean 14 Capital.
- Acquisition Acquires Primo.
Competitors of SyAqua
SyAqua has 3 listed competitors in our database, 3 of them funded. They include Avidity Biosciences, Sutro Biopharma and Antheia.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. |
Detailed competitors of SyAqua
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as SyAqua (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Syaqua
Complete news archive for SyAqua
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SyAqua
SyAqua was founded in 2001.
SyAqua is headquartered in Honolulu, United States. It is registered at Honolulu, Hawaii, United States.
SyAqua was established in 2001 by SyGen as a specific pathogen-free Penaeus vannamei shrimp breeding program. Based in Honolulu, United States, operations began at the University of California Berkeley, focusing on quantitative genetics. Best Linear Unbiased Prediction (BLUP) was pioneered for estimating breeding values without physical tagging. Since 2011, a genetic markers panel has been developed to identify genes linked to quantitative traits for parent selection in breeding candidates.
SyAqua's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
SyAqua offers Genetics Solutions, Nutrition and Health Products, and Facilities Consulting.
SyAqua has made 1 acquisition, including Primo.
SyAqua has 1 investor. Key investors include Ocean 14 Capital.
SyAqua operates through Syaqua Sdn Bhd.
Yes. SyAqua was acquired by Ocean 14 Capital in June 2022.

